Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Phathom Pharmaceuticals Inc
Change in Working Capital
Phathom Pharmaceuticals Inc
Change in Working Capital Peer Comparison
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
|
Change in Working Capital
$11.1m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
119%
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Change in Working Capital
-$94m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Change in Working Capital
-$356m
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pfizer Inc
NYSE:PFE
|
Change in Working Capital
-$5m
|
CAGR 3-Years
35%
|
CAGR 5-Years
69%
|
CAGR 10-Years
42%
|
|
Merck & Co Inc
NYSE:MRK
|
Change in Working Capital
-$2.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-24%
|
|
Eli Lilly and Co
NYSE:LLY
|
Change in Working Capital
-$5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-33%
|
See Also
What is Phathom Pharmaceuticals Inc's Change in Working Capital?
Change in Working Capital
11.1m
USD
Based on the financial report for Dec 31, 2023, Phathom Pharmaceuticals Inc's Change in Working Capital amounts to 11.1m USD.
What is Phathom Pharmaceuticals Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
119%
Over the last year, the Change in Working Capital growth was -43%. The average annual Change in Working Capital growth rates for Phathom Pharmaceuticals Inc have been -40% over the past three years , 119% over the past five years .